Cargando…
Promise and the Pharmacological Mechanism of Botulinum Toxin A in Chronic Prostatitis Syndrome
Chronic prostatitis/chronic pelvic pain syndrome (CP/ CPPS) has a negative impact on the quality of life, and its etiology still remains unknown. Although many treatment protocols have been evaluated in CP/CPPS, the outcomes have usually been disappointing. Botulinum neurotoxin A (BoNT-A), produced...
Autores principales: | Chen, Chien-Hsu, Tyagi, Pradeep, Chuang, Yao-Chi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832516/ https://www.ncbi.nlm.nih.gov/pubmed/31614473 http://dx.doi.org/10.3390/toxins11100586 |
Ejemplares similares
-
Pharmacological Sphincterotomy for Chronic Anal Fissures by Botulinum Toxin A
por: Wollina, Uwe
Publicado: (2008) -
Intraprostatic Botulinum Toxin injection in patients
with benign prostatic enlargement
por: Ilie, CP, et al.
Publicado: (2009) -
Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018) -
Botulinum Toxin: An Update on Pharmacology and Newer Products in Development
por: Choudhury, Supriyo, et al.
Publicado: (2021) -
The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A
por: Wang, Chung-Cheng, et al.
Publicado: (2020)